ClinConnect ClinConnect Logo
Search / Trial NCT05998499

HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort

Launched by HOSPITAL UNIVERSITARIO INFANTA LEONOR · Aug 16, 2023

Trial Information

Current as of August 02, 2025

Completed

Keywords

Asylum Seekers Migration Europe Latin America

ClinConnect Summary

Study Design and Setting This observational study was conducted between 2022 and 2023 in Madrid, Spain. Participants were recruited at the HIV outpatient clinic of Infanta Leonor University Hospital (HUIL) for the study and were monitored for a period of 6 months from their enrollment in the study.

Participant Recruitment Participants were primarily identified and referred by various non-governmental organizations (NGOs) working with migrants living with HIV. These NGOs, which included gTt-VIH, Apoyo Positivo, Cogam, Acción Triangulo, Kif-Kif, Salud Entre Culturas, and the Spanish Red Cros...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Latin American migrants infected with HIV who arrive in Spain with the intent to seek international protection and who lack access to healthcare.
  • Exclusion Criteria:
  • Those who do not give their consent

About Hospital Universitario Infanta Leonor

Hospital Universitario Infanta Leonor is a renowned academic medical center dedicated to advancing healthcare through innovative clinical research. As a leading sponsor of clinical trials, the hospital is committed to enhancing patient outcomes by exploring new therapeutic interventions and treatment modalities. With a multidisciplinary team of experienced researchers and healthcare professionals, Hospital Universitario Infanta Leonor fosters a collaborative environment that prioritizes patient safety and ethical standards. The institution plays a pivotal role in contributing to the body of medical knowledge, ultimately striving to translate research findings into effective clinical practices.

Locations

Madrid, , Spain

Patients applied

0 patients applied

Trial Officials

Pablo Ryan Murua, MD, PhD

Principal Investigator

Hospital Universitario Infanta Leonor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported